Cyclopropyl derivatives as nk3 receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 211/58 (2006.01) A61K 31/435 (2006.01) A61K 31/495 (2006.01) A61P 25/00 (2006.01) C07D 211/14 (2006.01) C07D 211/32 (2006.01) C07D 211/52 (2006.01) C07D 211/64 (2006.01) C07D 471/10 (2006.01) C07D 471/20 (2006.01)

Patent

CA 2535646

The present invention relates to cyclopropyl derivatives of formula (I) and salt thereof. These compounds are NK3 receptor antagonists and may therefore be useful for treatment of diseases where the NK3 receptor is implicated, e.g. psychotic disorders.

Cette invention se rapporte à des dérivés de cyclopropyle représentés par la formule (I) et à des sels de ces dérivés. Ces composés constituent des antagonistes du récepteur de NK3 et ils peuvent par conséquent être utiles pour le traitement des maladies dans lesquelles est impliqué le récepteur de NK3, par exemple les troubles psychotiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cyclopropyl derivatives as nk3 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cyclopropyl derivatives as nk3 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopropyl derivatives as nk3 receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1402938

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.